DE60230067D1 - Verwendung von estern langkettiger fettsäuren zur behandlung von autoimmunkrankheiten - Google Patents

Verwendung von estern langkettiger fettsäuren zur behandlung von autoimmunkrankheiten

Info

Publication number
DE60230067D1
DE60230067D1 DE60230067T DE60230067T DE60230067D1 DE 60230067 D1 DE60230067 D1 DE 60230067D1 DE 60230067 T DE60230067 T DE 60230067T DE 60230067 T DE60230067 T DE 60230067T DE 60230067 D1 DE60230067 D1 DE 60230067D1
Authority
DE
Germany
Prior art keywords
cis
unsaturated
saturated
fatty acid
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60230067T
Other languages
English (en)
Inventor
Pinchas Burstein
Avraham Ben-Nun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yeda Research and Development Co Ltd
Original Assignee
Yeda Research and Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research and Development Co Ltd filed Critical Yeda Research and Development Co Ltd
Application granted granted Critical
Publication of DE60230067D1 publication Critical patent/DE60230067D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60230067T 2001-04-11 2002-04-11 Verwendung von estern langkettiger fettsäuren zur behandlung von autoimmunkrankheiten Expired - Lifetime DE60230067D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL14253701A IL142537A0 (en) 2001-04-11 2001-04-11 Pharmaceutical compositions for the treatment of autoimmune diseases
PCT/IL2002/000296 WO2002083059A2 (en) 2001-04-11 2002-04-11 Use of esters of long-chain fatty acids for treatment of autoimmune diseases

Publications (1)

Publication Number Publication Date
DE60230067D1 true DE60230067D1 (de) 2009-01-08

Family

ID=11075314

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60230067T Expired - Lifetime DE60230067D1 (de) 2001-04-11 2002-04-11 Verwendung von estern langkettiger fettsäuren zur behandlung von autoimmunkrankheiten

Country Status (8)

Country Link
US (1) US8614248B2 (de)
EP (1) EP1480595B1 (de)
AT (1) ATE415157T1 (de)
AU (1) AU2002255242A1 (de)
DE (1) DE60230067D1 (de)
ES (1) ES2321166T3 (de)
IL (2) IL142537A0 (de)
WO (1) WO2002083059A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003233147B2 (en) 2002-05-13 2008-03-06 Arexis Ab Autoimmune conditions and NADPH oxidase defects
ITMI20030210A1 (it) * 2003-02-07 2004-08-08 Res & Innovation Soc Coop A R L Composti endocannabinoido-simili e loro impiego
US20050032892A1 (en) * 2003-08-07 2005-02-10 The Procter & Gamble Company Compositions, kits, and methods for treating gastrointestinal conditions
US7294739B1 (en) 2006-11-06 2007-11-13 Teva Pharmacaetical Industries Ltd. Basic amine esters or oleic acid and their use as anti-inflammatory or immunobodulatory agents
BRPI0821892A2 (pt) * 2008-01-28 2014-10-07 Mead Johnson Nutrition Co Composição nutricional contendo dha (ácido docosa-hexaenoico), ácido rumêncio e gangliosídeos
US8889739B2 (en) 2010-07-09 2014-11-18 President And Fellows Of Harvard College Use of trans-palmitoleate in identifying and treating metabolic disease
EP2869819A4 (de) * 2012-07-09 2016-03-09 Holden Brien Vision Inst Zusammensetzungen, verfahren und/oder vorrichtungen zur prävention und/oder behandlung des trockenen auges
FR3011467B1 (fr) 2013-10-08 2016-02-12 Centre Nat Rech Scient Composes et compositions comprenant de tels composes pour la prevention ou le traitement des dyslipidemies

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2515174A1 (fr) * 1981-10-23 1983-04-29 Roussel Uclaf Nouveaux triglycerides, procede de preparation et d'applications en dietetique et en therapeutique
US5231087A (en) * 1988-03-16 1993-07-27 Cellegy Pharmaceuticals, Inc. Treatment of skin diseases and tumors with esters and amides of monocarboxylic acids
JP3558351B2 (ja) * 1992-12-07 2004-08-25 邦郎 辻 免疫抑制剤
JPH06345644A (ja) * 1993-06-10 1994-12-20 Unitika Ltd 自己免疫性疾患治療剤
US5792774A (en) 1996-02-21 1998-08-11 Chiroscience Limited Quinolones and their therapeutic use
US5683698A (en) * 1996-08-02 1997-11-04 New England Deaconess Hospital Formulation for alleviating symptoms associated with arthritis
WO2001003688A2 (en) * 1999-07-09 2001-01-18 Pharmacia Corporation Treatment of cyclooxygenase-2 mediated disorders using conjugated fatty acid compounds
WO2001013956A2 (en) * 1999-08-26 2001-03-01 Ganeden Biotech, Inc. Use of emu oil a carrier for antifungal, antibacterial, and antiviral medications

Also Published As

Publication number Publication date
EP1480595A4 (de) 2005-05-11
ES2321166T3 (es) 2009-06-03
EP1480595A2 (de) 2004-12-01
US20040186072A1 (en) 2004-09-23
AU2002255242A1 (en) 2002-10-28
IL158228A (en) 2009-12-24
WO2002083059A2 (en) 2002-10-24
IL142537A0 (en) 2002-03-10
WO2002083059A3 (en) 2004-10-07
ATE415157T1 (de) 2008-12-15
US8614248B2 (en) 2013-12-24
EP1480595B1 (de) 2008-11-26

Similar Documents

Publication Publication Date Title
YU71495A (sh) Selektivno acilovanje e-amino grupa
ID15969A (id) Ester azabisiklik asam karbamat yang berguna dalam terapi.
DE60230067D1 (de) Verwendung von estern langkettiger fettsäuren zur behandlung von autoimmunkrankheiten
DE69927857D1 (de) Herstellung von ungesättigten Säuren oder von Säureestern und dafür geeignete Katalysatoren
DE58905425D1 (de) Verfahren zur Herstellung phosphorhaltiger L-Aminosäuren sowie ihrer Ester und N-Derivate.
ITBO20010429A0 (it) Metodi e dispositivi per idrolizzare gli esteri di acidi grassi naturali e successivamente esterificarli con metanolo in oli naturali sotto
IL142535A0 (en) Pharmaceutical compositions for the treatment of inflammation
HRP20041057A2 (en) Method and system for the esterification of fatty acids
DE69407846T2 (de) Verfahren zur Herstellung von Carbonsäuren oder ihrer Ester in gegenwart des auf Iridium basierten Katalysators
ATE366259T1 (de) Beta-amyloid-peptidaggregation regulierende peptide mit d-aminosäuren
IT1291995B1 (it) Miscela di esteri di acidi polialchilpiperidin-4-il bicarbossilici come stabilizzanti per sostanze organiche
GR3018691T3 (en) Amino acids, peptides or derivatives thereof coupled to fats
ITRM930399A0 (it) Uso di esteri della l-carnitina o di acil l- carnitine con idrossiacidi per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.
DE59504267D1 (de) Härten von ungesättigten fetten, fettsäuren oder fettsäureestern
DE59905405D1 (de) Verfahren zur Herstellung von Chinolon-und Naphthyridoncarbonsäuren und deren Ester
DE69811676T2 (de) Verfahren zur verminderung des gehaltes an langkettigen gesättigten fettsäuren in fettsäurezusammensetzungen
DE59906362D1 (de) Verwendung von lipopeptiden oder lipoproteinen zur wundbehandlung
ITRM930365A0 (it) Uso di esteri sull'ossidrile della l-carnitina con acidi aromatici perprodurre composizioni farmaceutiche per il trattamento di affezioni cutanee.
DE69717372D1 (de) Verfahren zur Herstellung von mit N-(langkettigen Acylgruppen) substituierten sauren Aminosäuren
DE69431637T2 (de) Verfahren zur Supplementierung von Aminosäuren an Wiederkäuern
DE60123564D1 (de) Verfahren zur Herstellung von Estern ungesättigter Carbonsäuren
IT1292126B1 (it) Esteri cerosi arricchiti in acidi grassi omega-3 insaturi,loro preparazione ed uso
DE59811028D1 (de) Verfahren zur Herstellung von Estern mit geringem Restsäuregehalt aus Alpha, Bêta-ethylenisch ungesättigten Carbonsäuren und Hydroxylgrupen-haltigen Polymerisaten
ATE292616T1 (de) Verfahren zur herstellung von rhizoferrin
ES2145259T3 (es) Procedimiento de obtencion de productos peptidicos.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition